Advances in the development of universal influenza vaccines. - Wikidata - awgldk - TriplyDB

Advances in the development of universal influenza vaccines.

Advances in the development of universal influenza vaccines.

http://www.wikidata.org/entity/Q30421502

about

The Possible Impact of Vaccination for Seasonal Influenza on Emergence of Pandemic Influenza via Reassortment.Bringing influenza vaccines into the 21st century.Adenoviral vectors as novel vaccines for influenza.Influenza virus surveillance in Argentina during the 2012 season: antigenic characterization, genetic analysis and antiviral susceptibility.Influenza epidemiology in Italy two years after the 2009-2010 pandemic: need to improve vaccination coverage.Fast vaccine design and development based on correlates of protection (COPs).Characterisation of a wild-type influenza (A/H1N1) virus strain as an experimental challenge agent in humans In Silico Identification of Highly Conserved Epitopes of Influenza A H1N1, H2N2, H3N2, and H5N1 with Diagnostic and Vaccination Potential Immunity against heterosubtypic influenza virus induced by adenovirus and MVA expressing nucleoprotein and matrix protein-1.Novel vaccine strategies against emerging viruses.Rise of the microbes.Vaccination potential of B and T epitope-enriched NP and M2 against Influenza A viruses from different clades and hosts.

P2860

Q30205724-0F59B894-A5B1-4227-8D19-55A478EBF494 Q30357413-4C7EDB25-D1AE-49D0-835E-64237CA37FBB Q30370445-5604CBC3-7C49-412B-BC78-0BCC6EC04ED3 Q30378860-F96FC1FE-1319-4C00-A86D-595D747AEDB9 Q30425550-C114792A-95E5-4F7C-86B2-AD674CED19C7 Q34291098-D52E0E49-9A7C-4D07-BDBD-5E96789C9B7A Q35066015-1850CC5C-D853-47EF-8A84-BFD941DE66A1 Q35982621-5AA6BAB0-AF7C-4CB5-8606-2AF41BE9E076 Q36679099-E6E00F4E-0418-4921-A06B-76BCEC5E0FB9 Q36816140-830AE4B4-915C-418C-8518-210D50633C35 Q37014766-54DF0C8E-D5B2-4918-89CB-BDAC2C3A4AAC Q47548294-07AEA3A8-F331-42D0-84FA-F096C936FE13

P2860

Advances in the development of universal influenza vaccines.

http://www.wikidata.org/entity/Q30421502

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

Advances in the development of universal influenza vaccines.

@ast

Advances in the development of universal influenza vaccines.

@en

type

label

Advances in the development of universal influenza vaccines.

@ast

Advances in the development of universal influenza vaccines.

@en

prefLabel

Advances in the development of universal influenza vaccines.

@ast

Advances in the development of universal influenza vaccines.

@en

P1433

Q30421502-B233DBF7-E788-4CEC-89C6-3B264CC94516

P1476

Q30421502-3D455090-EC1A-401A-B7D3-CF86E1184A79

P2860

Q30421502-1F821F66-6E82-41D6-A961-D3EF8C4FEB68

Q30421502-1FE4AE26-2B41-438B-91BC-406BB91C072E

Q30421502-221C672B-D4F9-446A-8C60-D1A32DC18FE1

Q30421502-24F94996-21BD-4812-954E-DCA5B967D7BE

Q30421502-2E0B7A83-FE54-4363-966A-6C0FD07AB822

Q30421502-315861C6-8AA6-48F9-890F-55BB26AB7527

Q30421502-3596D264-CF5F-46F8-9149-03F1B8513496

Q30421502-39163A0D-E75E-414D-BC8C-2FC5D494AD16

Q30421502-45B20316-B0E2-4C60-A6FC-AE0F9167B853

Q30421502-4A1F5711-3885-4D1F-8F2F-1CA11B225B05

P304

Q30421502-E849F678-8D64-472E-B5B9-23515E4B2843

P31

Q30421502-621FE6FD-C504-419F-90F9-D8F761DE5FB0

Q30421502-EF2F1978-E109-4AD6-8C28-6E9AE0103076

P356

Q30421502-34956C40-A5CD-4E43-82C2-114B4DEC13EC

P433

Q30421502-75A32EE3-B00E-4F53-B22C-B4A9EBB309CD

P478

Q30421502-C0D5C322-A998-49E4-9C97-94D2FA0C801C

P50

Q30421502-0CF0BAE5-B8A9-4287-9E89-97D9606F83A0

P577

Q30421502-992781EB-ADC0-4A2A-95D5-5CBEACDD46A2

Q30421502-E3188031-365A-4674-BBB7-95D53A04AAD7

P5875

Q30421502-49A4C3F2-DA89-4411-BD5D-5D5A9B9E14F7

P698

Q30421502-41FE50B4-236A-4A92-8FF3-80F4C30722BA

P921

Q30421502-3D0BA0AC-2072-4E74-B14B-C63797150AD8

Q30421502-57A4C5CE-C8FB-4F28-8F03-E4D4F7D45FD2

P932

Q30421502-23AD9D72-8DBC-4124-A73D-FD5D143808BD

P356

P1433

Influenza and Other Respiratory Viruses

P1476

Advances in the development of universal influenza vaccines.

@en

P2860

Influenza B Virus in Seals

Influenza vaccine given to pregnant women reduces hospitalization due to influenza in their infants

A highly conserved neutralizing epitope on group 2 influenza A viruses

Memory T cells established by seasonal human influenza A infection cross-react with avian influenza A (H5N1) in healthy individuals

Antibody recognition of a highly conserved influenza virus epitope

A neutralizing antibody selected from plasma cells that binds to group 1 and group 2 influenza A hemagglutinins

Safety and immunogenicity of AS03B adjuvanted split virion versus non-adjuvanted whole virion H1N1 influenza vaccine in UK children aged 6 months-12 years: open label, randomised, parallel group, multicentre study

Design of an HA2-based Escherichia coli expressed influenza immunogen that protects mice from pathogenic challenge.

Prior H1N1 influenza infection and susceptibility of Cleveland Family Study participants during the H2N2 pandemic of 1957: an experiment of nature.

Synthetic multi-epitope peptides identified in silico induce protective immunity against multiple influenza serotypes.

P304

750-758

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/IRV.12013

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

7

http://www.w3.org/2001/XMLSchema#string

P50

Sarah Catherine Gilbert

P577

2012-09-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

2013-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

263222160

http://www.w3.org/2001/XMLSchema#string

P698

22998622

http://www.w3.org/2001/XMLSchema#string

P921

P932

5781207

http://www.w3.org/2001/XMLSchema#string